Skip to main content
2024 Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Weifeng Tang, PhD

Executive Director
AstraZeneca plc

Weifeng is an Executive Director at AstraZeneca, heading a clinical pharmacology and quantitative pharmacology team to support Vaccines and Immune (V&I) Therapies and Neuroscience. Weifeng received his M.D. from Xiangya School of Medicine in China and Ph.D. from University of Rhode Island School of Pharmacy in USA. He started his pharmaceutical career in 2000 at Bayer and then joined AstraZeneca in 2007. Within AstraZeneca, Weifeng gradually increased his responsibilities over the time. As a professionally trained and accomplished physician scientist and clinical pharmacologist, Weifeng has >70 peer reviewed publications. Weifeng’s expertise covers early drug discovery to late clinical development and life cycle management, for multiple therapeutic areas. Weifeng appreciates the importance of M&S and applies MIDD in all stages of drug Discovery and developments. Weifeng is currently leading a cross function team to apply AI/ML in clinical pharmacology and quantitative pharmacology field.

Disclosure information not submitted.

Presentation(s):